Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type

BACKGROUND: While anti-SARS-CoV-2 vaccination success in kidney transplant recipients (KTR) after two doses and 1273-mRNA was associated with higher seroconversion rates compared to BNT162b2-mRNA in our “DIA-Vacc Study” (NCT04799808), it remains unclear whether this may also be the case in non-respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Stumpf, Julian, Schwöbel, Jörg, Karger, Claudia, Schirutschke, Holger, Mauer, René, Klimova, Anna, Tonn, Torsten, Hugo, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289185/
https://www.ncbi.nlm.nih.gov/pubmed/35860743
http://dx.doi.org/10.3389/fmed.2022.910987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289185/
https://www.ncbi.nlm.nih.gov/pubmed/35860743
http://dx.doi.org/10.3389/fmed.2022.910987

Ejemplares similares